Calcagni A, Luisi G, Lucente G, Pinnen F, Rossi D
Department of Pharmaceutical Studies, University La Sapienza, Rome, Italy.
Int J Pept Protein Res. 1990 Sep;36(3):240-6. doi: 10.1111/j.1399-3011.1990.tb00974.x.
Carboxy-activated linear peptides 6(a-c) of general formula Sal-Xaa-Pro-ONp (Xaa = Phe: Gly; Aib) were synthesized and treated at room temperature with 1,8-diazabicyclo [5,4,0] undec-7-ene (DBU) in benzene solution. The tetrahedral adducts (oxa-cyclols) 7, 11 and 12, tautomeric forms of the corresponding 10-membered cyclodepsitripeptides, have been isolated in each of the three models examined. These adducts, which contain the hydroxylated carbon atom located at the junction between two 6-membered rings, do not show a tendency to isomerize into the corresponding macrocyclic lactones, regardless of the nature of the substituents on the C alpha carbon atom of the central residue. Partially cyclized dimeric products 8 and 13, identified as N-(Sal-Xaa-Pro)-dioxopiperazines (Xaa = Phe;Aib), have been also isolated from the cyclization reactions.
合成了通式为Sal-Xaa-Pro-ONp(Xaa = Phe、Gly、Aib)的羧基活化线性肽6(a - c),并于室温下在苯溶液中用1,8 - 二氮杂双环[5,4,0]十一碳 - 7 - 烯(DBU)对其进行处理。在研究的三种模型中,均分离出了四面体加合物(氧杂环醇)7、11和12,它们是相应十元环缩肽的互变异构形式。这些加合物含有位于两个六元环连接处的羟基化碳原子,无论中心残基α - 碳原子上取代基的性质如何,它们都没有异构化为相应大环内酯的趋势。部分环化的二聚体产物8和13被鉴定为N -(Sal - Xaa - Pro)- 二氧代哌嗪(Xaa = Phe、Aib),它们也从环化反应中被分离出来。